Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gee

Showing results (101-110 of 419) with videos related to

Pageof 42
Sort By:
Optics Express|June 17, 2009
In vivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cellsDaniel C Gray, William Merigan, Jessica I Wolfing, et al.
Cytotherapy|June 4, 2002
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerI Braunschweig, N Q Mirza, G Rondon, et al.
Cytotherapy|September 15, 2022
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signalingMaria da Graça Cabreira, Xiaohong Wang, Andre Critsinelis, et al.
Cytotherapy|October 1, 2015
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potencyBahey Salem, Samantha Miner, Nancy F Hensel, et al.
BMC Ophthalmology|August 25, 2009
In-vivo imaging of retinal nerve fiber layer vasculature: imaging histology comparisonDrew Scoles, Daniel C Gray, Jennifer J Hunter, et al.
Cytotherapy|December 3, 2014
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppressionDebra D Bloom, John M Centanni, Neehar Bhatia, et al.
Cytotherapy|March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trialsPatrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Cytotherapy|January 19, 2010
CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicineDavid H McKenna, Sheryl Adams, Darin Sumstad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 13, 2005
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipientsTimothy C Lee, Barbara Savoldo, Cliona M Rooney, et al.
Blood|May 1, 2014
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15Yang Xu, Ming Zhang, Carlos A Ramos, et al.
Pageof 42

Showing results (101-110 of 419) with videos related to

Sort By:
Pageof 42
Optics Express|June 17, 2009
In vivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cellsDaniel C Gray, William Merigan, Jessica I Wolfing, et al.
Cytotherapy|June 4, 2002
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerI Braunschweig, N Q Mirza, G Rondon, et al.
Cytotherapy|September 15, 2022
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signalingMaria da Graça Cabreira, Xiaohong Wang, Andre Critsinelis, et al.
Cytotherapy|October 1, 2015
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potencyBahey Salem, Samantha Miner, Nancy F Hensel, et al.
BMC Ophthalmology|August 25, 2009
In-vivo imaging of retinal nerve fiber layer vasculature: imaging histology comparisonDrew Scoles, Daniel C Gray, Jennifer J Hunter, et al.
Cytotherapy|December 3, 2014
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppressionDebra D Bloom, John M Centanni, Neehar Bhatia, et al.
Cytotherapy|March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trialsPatrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Cytotherapy|January 19, 2010
CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicineDavid H McKenna, Sheryl Adams, Darin Sumstad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 13, 2005
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipientsTimothy C Lee, Barbara Savoldo, Cliona M Rooney, et al.
Blood|May 1, 2014
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15Yang Xu, Ming Zhang, Carlos A Ramos, et al.
Pageof 42